Hinova Pharmaceuticals Inc. A (688302) — Net Asset Quality Index
Hinova Pharmaceuticals Inc. A (688302) has a Net Asset Quality Index of 81.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.39 Billion minus total liabilities of CN¥255.12 Million yields net assets of CN¥1.14 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Hinova Pharmaceuticals Inc. A total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hinova Pharmaceuticals Inc. A Net Asset Quality Index Over Time (2019–2024)
This chart shows how Hinova Pharmaceuticals Inc. A's Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 81.7%, representing net assets of CN¥1.14 Billion against total assets of CN¥1.39 Billion CNY. For live market cap and overall valuation, see 688302 stock market capitalisation.
Annual Net Asset Quality Index for Hinova Pharmaceuticals Inc. A (2019–2024)
The table below presents the year-by-year Net Asset Quality Index for Hinova Pharmaceuticals Inc. A from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Hinova Pharmaceuticals Inc. A (688302) net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 87.6% | CN¥1.19 Billion | CN¥1.36 Billion | CN¥169.33 Million | ▼ -4.1 pp |
| 2023 | 91.7% | CN¥1.37 Billion | CN¥1.49 Billion | CN¥124.47 Million | ▲ +0.3 pp |
| 2022 | 91.4% | CN¥1.59 Billion | CN¥1.74 Billion | CN¥149.68 Million | ▲ +11.1 pp |
| 2021 | 80.3% | CN¥788.76 Million | CN¥982.35 Million | CN¥193.59 Million | ▼ -2.7 pp |
| 2020 | 83.0% | CN¥986.15 Million | CN¥1.19 Billion | CN¥202.33 Million | ▲ +163.0 pp |
| 2019 | -80.0% | CN¥-35.78 Million | CN¥44.72 Million | CN¥80.50 Million | — |